Sort
40,608 grants matching “prostate cancer”
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$727,088William Laurence Dahut · Clinical Sciences · Z01 · FY2007 · CA
Epigenetic aging as a driver of racial disparities in early onset prostate cancer
$726,928Anna Woloszynska-Read · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
PROSTATE CANCER CLINICAL TRIALS CONSORTIUM: JOHNS HOPKINS KIMMEL CANCER CENTER SITE
$726,921The Johns Hopkins University · · FY2014 · Department of the Army
Career Development in Pediatric and Medical Oncology
$726,905Soheil Meshinchi · Fred Hutchinson Cancer Center · K12 · FY2022 · CA
Radiation-induced translational control of gene expression
$726,840Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
(3 of 3) MMC, VICC & TSU: Partners in Eliminating Cancer Disparities
$726,440Margaret M Whalen · Tennessee State University · U54 · FY2022 · CA
3D Prostate Cancer Imaging Based on "Crawling Wave" Excitation
$726,408Deborah J. Rubens · University Of Rochester · R01 · FY2007 · AG
Core 2
$726,297Andrea Califano · Columbia University Health Sciences · U54 · FY2014 · CA
MR GUIDED PROSTATE CANCER DIAGNOSIS AND BRACHYTHERAPY
$726,095Brigham And Women'S Hospital · R01 · FY2002 · AG
P3IK Signaling and Biology of Therapeutic Response in Brain and Prostate Tumors
$725,951Eric C Holland · Fred Hutchinson Cancer Research Center · U01 · FY2013 · CA
Descriptive Studies and Record Linkage
$725,750William Anderson · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Breast and Ovary Cancer Clinical Validation Center
$725,717Christopher I Li · Fred Hutchinson Cancer Research Center · U01 · FY2014 · CA
Developmental Reprogramming of Prostate Carcinogenesis by BPA
$725,548Cheryl L Walker · University Of Tx Md Anderson Can Ctr · RC2 · FY2010 · ES
Tissue ProcessingSequencing Core
$725,535Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
ERADICATING METASTATIC PROSTATE CANCER THROUGH THE SYSTEMATIC IDENTIFICATION OF SYNERGISTIC DRUG COMBINATIONS
$725,378Monash University · · FY2018 · Defense Health Agency
10-year Comparative Effectiveness and Harms of Treatments for Prostate Cancer
$725,269Daniel A Barocas · Vanderbilt University Medical Center · R01 · FY2019 · CA
Exercise as Interception Therapy in Primary High Risk Cancer
$725,188Lee W Jones · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
PROSTATE CANCER DNA METHYLATION PROFILING BY ADVANCED 3-D IMAGING
$725,138Cedars-Sinai Medical Center · · FY2010 · Department of Defense
REGULATORY MECHANISMS OF PROSTATE TUMOR PROGRESSION
$725,000Cleveland Clinic Foundation · P50 · FY2002 · DK
REGULATORY MECHANISMS OF PROSTATE TUMOR PROGRESSION
$725,000Cleveland Clinic Foundation · P50 · FY2000 · DK
REGULATORY MECHANISMS OF PROSTATE TUMOR PROGRESSION
$725,000Cleveland Clinic Foundation · P50 · FY2001 · DK
Ultra-Low Background NIR Fluorophores for In Vivo Imaging and Image-Guided Surger
$724,966John V Frangioni · Beth Israel Deaconess Medical Center · R01 · FY2010 · EB
Enabling Technologies for MRI-Guided Prostate Interventions
$724,921Clare M Tempany · Brigham And Women'S Hospital · R01 · FY2015 · CA
Development Of Drugs Acting At Adenosine Receptors
$724,885Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Delineating the underlying reasons for the racial disparity in gastric cancer incidence in the United States
$724,814Meira Epplein · Duke University · R01 · FY2022 · CA